Cargando…

Biosimilars: The naming puzzle

Detalles Bibliográficos
Autor principal:	Gaur, Rajneesh Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450568/ https://www.ncbi.nlm.nih.gov/pubmed/26069380 http://dx.doi.org/10.4103/0253-7613.157140

Ejemplares similares

Antibiotic resistance: Alternative approaches
por: Gaur, Rajneesh Kumar
Publicado: (2017)

Ophthalmic biosimilars: Lessons from India
por: Sharma, Ashish, et al.
Publicado: (2019)

Naming no names: Comments on the taxonomy of small piroplasmids in canids
por: Harris, D. James
Publicado: (2016)

A Puzzle
Publicado: (1891)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Solving extubation puzzle with Intubating fibrescope
por: Bhardwaj, Manoj, et al.
Publicado: (2020)

Puzzling Persistent Anterior Cervical Pain: to Be or Not to Be?
por: Sengul, Ilker, et al.
Publicado: (2021)

Naming Global Health
por: Brett-Major, David
Publicado: (2011)

Immune system elements - a puzzle in CRS
por: Kowalik, Katarzyna, et al.
Publicado: (2022)

Recurrent Cardiac Myxoma: A Puzzle to be Solved
por: Yalta, Kenan, et al.
Publicado: (2023)

Biosimilar insulins: An unavoidable option in South-East Asia
por: Kaduskar, Prashant Ulhas
Publicado: (2016)

Puzzling increase and decrease in COVID-19 cases in Pakistan
por: Shah, P.T., et al.
Publicado: (2020)

Reply to the editorial – “Only generics (drugs/names): Is India ready?”
por: Sahay, Rakesh Kumar, et al.
Publicado: (2016)

Comment on “Biosimilar FSH preparations- are they identical twins or just siblings?”
por: Strowitzki, Thomas, et al.
Publicado: (2016)

Comment on “The End of Phase 3 Clinical Trials in Biosimilars Development?”
por: Webster, Christopher J., et al.
Publicado: (2018)

The fractionation conundrum: Are we still missing a piece of the puzzle?
por: Mummudi, Naveen, et al.
Publicado: (2013)

A Puzzling “Switch” in Blood Type Following Blood Transfusion
por: Akria, Luiza, et al.
Publicado: (2017)

PSYCHOTROPIC DRUGS : WHAT'S IN A NAME ?
por: Andrade, Chittaranjan
Publicado: (1996)

What is in a name: Is it Nelson's syndrome?
por: Gundgurthi, Abhay, et al.
Publicado: (2012)

Sand Fly Fever with Different Names
por: Mehrabi-Tavana, Ali
Publicado: (2017)

What is the name of this book?: the riddle of Dracula and other logical puzzles
por: Smullyan, Raymond M
Publicado: (1978)

What is the name of this book?: the riddle of Dracula and other logical puzzles
por: Smullyan, Raymond M
Publicado: (1981)

Cancer Immunotherapy for Immunocompromised Patients: An Often Ignored, yet Vital Puzzle
por: Bajpai, Jyoti
Publicado: (2020)

Reply to Letter to the Editor: “Recurrent Cardiac Myxoma: A Puzzle to be Solved”
por: Yalçınkaya Öner, Damla, et al.
Publicado: (2023)

Fab-arm exchange: What’s in a name?
por: Schuurman, Janine, et al.
Publicado: (2012)

New Phylum Names Harmonize Prokaryotic Nomenclature
por: Oren, Aharon, et al.
Publicado: (2022)

Biosimilars: Current regulatory perspective and challenges
por: Jha, Diwakar, et al.
Publicado: (2013)

Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020)

Puzzling postoperative toxin-induced acute liver failure after nonhepatobiliary surgery
por: Navas-Blanco, Jose R., et al.
Publicado: (2018)

Puzzle and Challenge in Routine Extrahepatic Bile Duct Resection for Advanced Gallbladder Carcinoma
por: Liu, Fei, et al.
Publicado: (2020)

Reconstructing the puzzle of the role of therapeutic endoscopy in the management of post-bariatric surgery complications
por: Argyriou, Konstantinos, et al.
Publicado: (2022)

Antegrade Versus Retrograde Cholecystectomy: What’s in a Name?
por: Pran, Lemuel, et al.
Publicado: (2017)

HLA-genotyping and the historical naming process of an old disorder
por: Evereklioglu, Cem
Publicado: (2022)

Subacute Sclerosing Panencephalitis: A Name with Many Faces
por: Agarwal, Ayush, et al.
Publicado: (2022)

Biosimilar Naming Conventions: Pharmacist Perceptions and Impact on Confidence in Dispensing Biologics
por: Tomaszewski, Daniel
Publicado: (2016)

Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016)

Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
por: Hassett, Brian, et al.
Publicado: (2018)

Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars
por: Cohen, Hillel P.
Publicado: (2018)

Comment on: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
por: Pires, Antonio, et al.
Publicado: (2018)

bDMARDs retention rate in the biosimilar era: A real-life monocentric study
por: Becciolini, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4icek3npeaqsatbne444v9tdnv